Why 60% of Denied Claims Are Never Appealed — And Why That’s Costing Healthcare Practices Millions

Claim denials have become a structural problem in healthcare revenue cycles. In 2026, most practices are not losing revenue because claims are denied — they are losing revenue because denied claims are never appealed.

Industry data shows that nearly 60% of denied claims are abandoned before any appeal is submitted. These are not invalid claims. They are services that were rendered, documented, and billable — but never recovered.

This silent revenue loss adds up to millions of dollars annually for mid- to large-sized practices.

Denials Are Not the End of the Revenue Cycle

A denied claim is not a rejection of care. It is a request for clarification, validation, or documentation — often triggered by automated payer systems.

Many denials are issued due to:

  • Missing or mismatched documentation

  • Authorization inconsistencies

  • Coding aligned with CPT rules but not payer policy

  • Medical necessity interpretations

When appealed correctly, a significant percentage of denied claims are paid.

The problem is not recoverability.
The problem is follow-through.

Why Most Denied Claims Are Never Appealed

Limited Operational Capacity

Appeals require clinical review, payer policy alignment, and consistent follow-up. Most billing teams are designed to process volume, not manage complex denial workflows. As daily billing demands increase, appeals are deprioritized.

Payer-Specific Complexity

Each payer enforces unique appeal timelines, documentation standards, and submission channels. Without payer-specific appeal workflows, practices struggle to submit compliant appeals before deadlines expire.

Underestimating Low-Dollar Denials

Individual low-balance denials appear insignificant. In aggregate, they represent a substantial revenue loss. Hundreds of small write-offs often exceed the value of a few high-dollar recoveries.

Misconceptions About Denial Finality

Many practices assume that a denial indicates non-payability. In reality, payers frequently reverse decisions when presented with appropriate documentation and payer-aligned clinical justification.

Lack of Ownership and Accountability

Without defined responsibility, denial follow-up becomes fragmented. Claims age out, deadlines are missed, and recoverable revenue is written off without review.

The Financial Impact of Unappealed Denials

Even modest denial rates can produce outsized losses.

For example:

  • A practice with $10 million in annual billings

  • 10% of claims denied

  • 60% left unappealed

This results in hundreds of thousands of dollars in unrecovered revenue each year — revenue that directly impacts cash flow, staffing, and growth.

How Unappealed Denials Affect Long-Term Performance

Revenue loss from denials extends beyond write-offs. It leads to:

  • Elevated A/R days

  • Inconsistent cash flow

  • Distorted financial reporting

  • Reduced operational efficiency

  • Lower enterprise valuation

Denial abandonment quietly erodes financial stability.

How High-Performing Practices Approach Denials

Successful practices treat denied claims as recoverable assets, not administrative failures.

They implement:

  • Structured denial categorization and prioritization

  • Payer-specific appeal strategies

  • Defined timelines and escalation paths

  • Continuous root-cause analysis to prevent recurrence

This approach improves both short-term recovery and long-term denial reduction.

Why Denial Appeals Matter More in 2026

Payers are increasing:

  • Automated claim edits

  • Medical necessity enforcement

  • Prior authorization audits

  • Denial-driven compliance reviews

Practices that fail to appeal denials consistently face increasing revenue leakage and heightened audit exposure.

The Strategic Advantage of Specialized Denial Management

Many organizations are turning to specialized denial management partners to:

  • Scale appeal volume without internal strain

  • Improve appeal success rates

  • Maintain payer compliance

  • Recover revenue faster

The result is a more predictable, resilient revenue cycle.

Final Thoughts

Denied claims represent earned revenue under review, not lost revenue.
When claims are not appealed, practices voluntarily surrender payment for services already provided.

Reducing denial abandonment is not about working harder — it is about working strategically.

Why 60% of Denied Claims Are Never Appealed — And Why That’s Costing Healthcare Practices Millions
Next
Next

Radiology CPT Coding Errors That Put Practices on Payer Audit Watchlists in 2026